Results 261 to 270 of about 163,785 (367)

Comparison of Beta-Blocker Effectiveness in Heart Failure Patients With Preserved Ejection Fraction Versus Those With Reduced Ejection Fraction [PDF]

open access: green, 2013
Mostafa El-Refai   +7 more
openalex   +1 more source

Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction

open access: yesCirculation, 2017
M. Obokata   +4 more
semanticscholar   +1 more source

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad   +9 more
wiley   +1 more source

The use of echocardiography and echocardiographic findings in patients hospitalized for acute heart failure

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Transthoracic echocardiography (TTE) is recommended as a key investigation in patients with acute heart failure (AHF) in major guidelines. However, utilization and benefits are yet to be known in Thai patients. The study aims to evaluate the benefits of TTE and identify factors associated with the decision to perform TTE on patients with ...
Koravich Lorlowhakarn   +9 more
wiley   +1 more source

LACK OF CARDIAC MYOSIN BINDING PROTEIN-C PHOSPHORYLATION IS A MODEL OF HEART FAILURE WITH PRESERVED EJECTION FRACTION

open access: bronze, 2012
Carl W. Tong   +5 more
openalex   +1 more source

Home - About - Disclaimer - Privacy